Mutations in the tumor suppressor p53 are a common event in hepatocellular carcinoma (HCC). Because HCCs typically occur in livers with chronic injury and impaired function, we have explored the role of wild-type p53 in regulating the growth and dierentiation of Hep 3B hepatoma cells, a p53-negative line derived from a liver cancer. Stable Hep 3B cell lines were generated in which inducible p53 was introduced using either a temperature-sensitive mutant (p53val135) or a tamoxifen-regulated p53-estrogen receptor chimera (p53-mER tm -pBabepuro). In both cell lines, induction of transcriptionally active p53 was con®rmed by assessing several p53 targets: Mdm2 protein, p21 waf1 mRNA and protein, and the cyclin G promoter. Despite marked induction of p21 waf1 , cells with active p53 failed to undergo growth arrest, which is probably due to the presence of a non-functional retinoblastoma protein (pRb) in these cells. Apoptosis also was not observed, even after prolonged (48 h) serum starvation or exposure to cisplatinum. Lack of apoptosis was correlated with unchanged bax mRNA levels following p53 induction. Additionally, albumin mRNA levels remained unchanged, and there was no change in basal transactivation of a reporter containing the promoter of the haptoglobin gene, encoding an acute phase protein. This suggests that growth arrest may be required to promote liver-speci®c gene expression. Overall, our data demonstrate that introduction of transcriptionally active p53 does not alter the malignant, dedierentiated phenotype of Hep 3B hepatoma cells. Hence, not all cancer cells are equally responsive to the re-activation of wild-type 53. The
Introduction
Characterization of p53's activities and identi®cation of its transcriptional targets have greatly elucidated its role in human neoplasia and in normal development (Gottlieb and Oren, 1996; Ko and Prives, 1996) . p53 can induce a growth arrest, often in G1 phase of the cell cycle and sometimes also in G2 (reviewed in Gottlieb and Oren, 1996; Ko and Prives, 1996) . This relies in part upon transcriptional activation of the p21 waf1 gene, which encodes an inhibitor of cyclindependent kinases (el-Deiry et al., 1993) . In normal cells, induction of p21 waf1 by p53 leads to hypophosphorylation of the retinoblastoma protein (pRb), preventing its dissociation from the transcription factor E2F, and rendering E2F unable to transactivate genes required for S phase entry and DNA synthesis (Nevins, 1992; Weinberg, 1996) . The p53 target gene mdm2 (Barak et al., 1993; Wu et al., 1993) encodes several polypeptides . It can act as an oncogene (Fakharzadeh et al., 1991) , presumably by binding to p53 and suppressing its activity (Oliner et al., 1993) . Another transcriptional target of p53 is gadd45 (Kastan et al., 1992) , whose protein product binds PCNA (proliferating cell nuclear antigen), and may be involved in promoting DNA repair (Smith et al., 1994) . The list of established and candidate p53 target genes is growing steadily (reviewed in Gottlieb and Oren, 1996; Ko and Prives, 1996) .
In addition to its role in growth regulation, p53 may also contribute to tumor suppression by detecting DNA damage and by promoting apoptosis of cells with damaged genomes. One pathway by which this occurs may be via transactivation of the bax gene (Miyashita and Reed, 1995) , encoding a functional antagonist of the cell survival-promoting protein Bcl-2 (Williams and , and presumably of additional apoptosisrelated genes (Friedlander et al., 1996) . p53 may also promote apoptosis through mechanisms which do not rely on its function as a sequence-speci®c transcriptional activator (Caelles et al., 1994; Haupt et al., 1995; Wagner et al., 1994) .
A role for p53 in cell dierentiation has also emerged. Expression of p53 has been associated with increased expression of dierentiation markers in B cell lines (Shaulsky et al., 1991) , keratinocytes (Weinberg et al., 1995) , as well as in spermatogenesis (Gottlieb and Oren, 1996) for reviews. More recently, induction of dominant negative mutant p53 activity has been correlated with decreased terminal dierentiation in both myogenic and hematopoetic cell lines (Soddu et al., 1996) . Hepatocellular carcinoma (HCC) is a highly prevalent consequence of chronic liver disease worldwide, and is often associated with mutations in the tumor suppressor p53 (see Tabor, 1994 for review) . Typically hepatocellular carcinoma occurs in patients with longstanding liver disease due to Hepatitis B or C infection, alcohol abuse, or inherited metabolic disease such as iron overload. As in other neoplasms, mutations in p53 often contribute to the malignant phenotypic of hepatocellular cancer, although these mutations are heterogeneous with respect to the prevalence and site, depending on the geographic region and underlying disease (Tabor, 1994) . For example, a high prevalence of codon 249 mutations in regions of high a¯atoxin exposure has been linked to a¯atoxin-induced G to T transversions (Bressac et al., 1991; Hsu et al., 1991) whereas codon 249 mutations are less common in other regions (Hosono et al., 1993; Unsal et al., 1994) . Mutations in pRb have also been associated with p53 mutations in HCC (Puisieux et al., 1993b; Seki et al., 1995; Zhang et al., 1994) , which may accelerate the neoplastic process.
The fact that hepatocellular carcinoma occurs primarily in patients with chronic liver disease and impaired dierentiated function (i.e. reduced albumin expression) suggests that p53 inactivation might independently contribute to loss of dierentiation in these patients. To address the eect of p53 on dierentiation, growth, and survival of hepatic carcinoma cells, we generated Hep 3B-derived stable lines in which wild-type p53 expression can be induced deliberately. Hep 3B cells are particularly appropriate because they lack p53 (Bressac et al., 1990) . Two mechanistically distinct systems were employed to regulate p53 activity: a temperature sensitive mutant of p53 (Michalovitz et al., 1990) , and a modi®ed p53-estrogen receptor chimera in which p53 activity is induced post-translationally by addition of the speci®c ligand 4-OH tamoxifen (Vater et al., 1996) . Using this approach we have examined the impact of p53 expression on growth, response to DNA damage and dierentiation in Hep 3B cells. We report here that neither growth arrest nor dierentiation, or apoptosis could be elicited by activation of p53 in these cells. Our data imply that certain types of cancer cells can be refractory to the`tumor suppressor' eects of p53. Hence, a successful response of cancer cells to p53 reactivation may require the retention of at least some intact downstream eector pathways.
Results
Hep 3B cells transiently transfected with p53mER tm -pBpuro express inducible, transcriptionally active p53
To determine the feasibility of generating Hep 3B clones expressing a tamoxifen-regulated p53-estrogen receptor chimera, cells were ®rst transiently transfected with a plasmid encoding such a chimera (p53mER tmpBpuro) together with a reporter plasmid containing the ®re¯y luciferase gene downstream to the cyclin G promoter. The cyclin G promoter is a transcriptional target of p53 (Zauberman et al., 1995) . As shown in Figure 1 , reporter activity was stimulated 3.6-fold in the presence of 100 nM 4-OH tamoxifen (4-OH TM) as compared to co-transfected cells maintained without 4-OH TM. This demonstrates that the chimeric protein is indeed active as a transcriptional activator, and that its activity can be experimentally manipulated.
Construction of Hep 3B clones stably expressing inducible p53 activity
Having established that transfection of the chimeric protein yielded inducible, transcriptionally active p53, stable cell lines were next generated expressing either this p53-(modi®ed) estrogen receptor chimera or the temperature sensitive mutant p53val135. Several independent clones were obtained in each case. For the p53-estrogen receptor-expressing clones, Western blot analysis (Figure 2 ) demonstrated variable degrees of expression of the chimera at the expected size of 95 kD (the receptor has an apparent molecular mass of approximately 40 kD). Interestingly, whereas p53 in the p53val135-expressing clones was detectable with the p53-speci®c monoclonal antibody PAb 421, the p53-estrogen receptor chimera was not recognized by this mAb, although retaining reactivity with PAb 1801 and DO-1. The Pab 421 epitope is in the C-terminal domain of p53 (Harlow et al., 1981) whereas the other two mAbs recognize more N-terminal epitopes. This ®nding suggests that fusion of the receptor to the C-terminal domain of p53 may render the epitope inaccessible. Moreover, in those clones with low expression of p53-mER tm , addition of 4-OH TM increased the apparent amount of chimeric protein (not shown). For both p53-mER tm and p53val135 clones, expression and inducibility were stable up to at least 30 passages (data not shown).
For subsequent analyses, all experiments used the following representative clones (except where indicated): Clone BT-2E: Puromycin resistance only 5 Hep 3B cells were transfected with 1 mg each of cyclin G luciferase reporter, and 1 mg each of either pBpuro or p53-mER tm -pBpuro. Six hours later, cells were brie¯y exposed to 10% glycerol, then 4-OH tamoxifen was added at the indicated concentrations. Twenty-four hours after transfection the cells were harvested for luciferase assay as described in Materials and methods. Data shown represents mean of triplicate values, with 510% standard deviation among replicates. Findings were reproducible in three separate assays
112 kD -84 kDp53-mERtm-pB puro Transfected cDNA:
pB puro p53 is uniformly expressed within Hep 3B clones containing p53val135
To ensure that the majority of cells within each puromycin-resistant clone expressed the transfected p53, cells from clone 4Bv were stained for p53 following incubation for 24 h at 328C, and compared to control cells expressing puromycin resistance alone (Clone BT-2E) (Figure 3 ). At 328C, more than 90% of the clone 4Bv cells displayed nuclear staining of variable intensity. No immunoreactivity was apparent in clone BT-2E, con®rming the p53-negative status of the parental Hep 3B cell line (Bressac et al., 1990) .
Inducible p53 in stable Hep 3B lines is transcriptionally active
Transcriptional activity towards several p53 targets was assessed following activation of p53 in clone 4Bv by temperature shift, or in clone BT-4P following addition of 4-OH TM, respectively. In clone BT-4P activation of the cyclin G luciferase reporter (Figure 4 ) was comparable to that observed in cells transiently transfected with the p53 chimera (compare to Figure  1 ). Substantial induction of Mdm2 protein was documented in both clones ( Figure 5 ). Signi®cant Mdm2 induction was apparent in clone BT-4P within 2 h after addition of ligand to clone BT-4P (data not shown), as well as in a separate clone (clone BT-4K). A marked induction of p21 waf1 mRNA and protein was apparent in both clones following activation of p53, as assessed by semi-quantitative RT ± PCR (not shown) and Western blot ( Figure 6 ). 5 cells from cell line 4Bv were harvested following 24 h at either 328C or 378C or in BT-4P cells following 4-OH tamoxifen exposure at the indicated times and concentrations. Extracts were subjected to Western blotting analysis. Mdm2 protein was detected using monoclonal antibody SMP-14 Figure 4 Cyclin G luciferase transactivation in Clones BT-2E and BT-4P following p53 induction. Cell lines BT-2E and BT-4P were plated at a density of 2.5610 5 cells per 60 mm plate and transfected with 1 mg cyclin G luciferase reporter. Six hours later the cells were brie¯y treated with 10% glycerol, after which 4-OH tamoxifen was added at the indicated concentrations for 18 h, followed by luciferase assay. Data represents triplicate determinations. Standard deviation was less than 10% among replicates; ®ndings were reproducible in two separate experiments Hep 3B cell lines expressing transcriptionally active p53 do not undergo growth arrest or apoptosis Cell cycle analysis following activation of p53 failed to detect any growth arrest in either clones 4Bv and BT-4P despite the high levels of p21 ( Figure 7) . Moreover, by FACS analysis there was no apparent p53-dependent increase in sub-diploid apoptotic cells. Because p53-mediated apoptosis may sometimes be elicited only after either serum starvation (Evan et al., 1992) or DNA-damage Gottlieb et al., 1994; Lowe et al., 1993) , these conditions were also tested (Tables 1 and 2 ), yet no p53-dependent apoptosis was observed. Unlike the marked induction of mdm2 and p21 waf1 , bax mRNA levels remained unchanged following p53 activation (data not shown). This might explain, at least in part, the lack of p53-mediated apoptosis.
Hep 3B cell lines have low levels of pRb which is constitutively hypophosphorylated and unresponsive to p53 activation Because in normal cells p21 induction leads to reduced pRb phosphorylation and to growth arrest, we assessed pRb expression before or after activation of p53. Although a previous report suggested that Hep 3B cells do not have pRb detectable by metabolic labeling (Puisieux et al., 1993a) , Western blot in fact demonstrated this protein (Figure 8 ). However, pRb was expressed in very low amounts (note that the extract from H1299/p53val135 cells, serving as a control in lane 1, represents one-tenth the number of cells than the Hep 3B-derived extracts in lanes 2 ± 8). Moreover, comparison with the functional pRb in lane 1 reveals that the pRb in Hep 3B cells and in their transfection-derived clones is constitutively hypophosphorylated, and its phosphorylation pattern is unaected by cellular p21 levels. These features are highly suggestive of a non-functional pRb (Buchkovich et al., 1989; Chen et al., 1989; Mihara et al., 1989) .
p53 activation in the absence of growth arrest fails to increase dierentiated liver gene expression or transactivate an acute phase gene
The ability of p53 to increase expression for albumin mRNA, the classical marker of dierentiated liver function, was tested. No increase in albumin mRNA was seen following p53 induction for up to 3 days ( Figure 9 ). There was, however, some temperaturerelated increase in albumin mRNA at 24 h in both control cells (Clone BT-2E) and cells expressing p53val135 (Clone 4Bv). , mdm2 and the cyclin G promoter. Highly consistent ®ndings were obtained with two mechanistically distinct modes of activating p53. The lack of growth arrest in spite of high levels of p21 is explained, at least in part, by the presence of very low amounts of pRb which is non-functional and nonresponsive to p21. This ®nding implies that p21 induction is not sucient, by itself, to impose a p53-mediated growth arrest. Rather, the growth inhibitory eect of p21 (and, by inference, p53) depends on the retention of at least some functional downstream eector pathways, most notably an intact pRb protein. Hence, tumor cells in which all the pertinent downstream pathways may have been disrupted may become refractory to the inhibitory eects of wild-type p53.
Other pathways of growth arrest independent of p53 and pRb may also be important in these liver cells. For example, in Hep 3B2 cells (a subline of Hep 3B), growth arrest occurs following transient transfection and expression of the transcription factor CCAAT/ enhancer binding protein a (C/EBP a) (HendricksTaylor and Darlington, 1995), a factor which is normally expressed at very low levels in these rapidly dividing cells. Interestingly, a recent study demonstrates that in 3T3-L1 adipocytes, C/EBP a transactivates a reporter containing the promoter of the gadd45 gene (Constance et al., 1996) , which is also a transcriptional target of p53 (Kastan et al., 1992; Smith et al., 1994) . Thus, two pathways of growth arrest ± p53 and C/EBP a ± may converge on gadd45.
Although pRb is present in Hep 3B cells based on our ®ndings, a recent study strongly indicates a lack of functional pRb in this cell type (Hsia et al., 1994) because the authors failed to detect nuclear pRb in Hep 3B cells by immunocytochemistry. Dual mutations in tumor suppressor genes are a common ®nding in BT-2E  BT-4P  4Bv  BT-2E  BT-4P  BT-2E  BT-4P  BT-2E  BT-4P  BT-2E  4Bv  BT-2E  4Bv  BT-2E  4Bv   37°C  1d tm 2d tm 3d tm 1d 32°2d 32°3d 32°C ell Line: Figure 9 Albumin mRNA expression as detected by Northern blot in Hep 3B cell lines is unchanged following activation of p53. Cells from each of the Hep 3B cell lines were harvested following either treatment of BT-4P cells with 4-OH tamoxifen (tm) for 1, 2 or 3 days, or 328C incubations for similar intervals in 4Bv cells. For each condition, 15 mg total RNA were analysed for albumin mRNA expression by Northern blot. The corresponding ethidium bromide-stained gel prior to transfer is shown in the lower panel, with 28 and 18S ribosomal bands evident tumors, and supports the view that carcinogenesis is a multistep process in which consecutive mutations are accrued that collectively confer a malignant phenotype. Hepatocellular carcinomas in particular often have mutations in both pRb and p53 (Puisieux et al., 1993a; Seki et al., 1995; Zhang et al., 1994) . Since our data demonstrate a lack of growth arrest despite p53 activation, it is unclear why Puisieux et al. (1993b) was unable to achieve sustained wild-type p53 expression following transfection of wild-type p53 and neomycin selection in Hep 3B cells. Perhaps neither the temperature sensitive p53 nor the p53-estrogen receptor chimera can confer all activities of authentic wild-type p53, and particularly those involved with p53-mediated apoptosis. It is of note, however, that both constructs can confer apoptosis in other cell contexts (Johnson et al., 1993; Ryan et al., 1993; Vater et al., 1996; YonishRouach et al., 1991) . Therefore, the absence of apoptosis following p53 induction in our Hep 3B lines is not as easily explained as the lack of growth arrest. One possible explanation may lie in the lack of bax activation, although p53 can induce apoptosis even in the complete absence of bax, at least in some cell types (Knudson et al., 1995) . The phenotype of Hep 3B cells may de®ne a class of tumor cells which, for unknown reasons, does not display either p53-mediated induction of bax or bax-independent apoptosis. Regardless, the ®ndings underscore the remarkable resistance of this cell type to apoptotic stimuli, and could explain in part the refractoriness of HCC to chemo-and radiation therapies in patients with this disease (Ramsey and Wu, 1995) .
While p53 may contribute to dierentiation in some cell types, our data suggests that in Hep 3B cells increased expression of a dierentiation marker does not occur in the absence of growth arrest. The association between growth arrest and dierentiation has been observed in a large number of cell types (Constance et al., 1996; Minami et al., 1996) and in hepatocytes both may be mediated in part by C/EBP a (Hendricks- Taylor and Darlington, 1995) . Thus, the failure of p53 to promote dierentiation in the absence of growth arrest is not surprising since there are no p53 consensus sequences in the albumin promoter; there are, however, consensus sequences which bind C/EBP a (Chojkier, 1995) .
The lack of growth arrest or apoptosis in Hep 3B cells despite transcriptionally active p53 could prove to be a very useful tool for dissecting activities of p53 which might not be apparent if either of these responses occurred. These might include opportunities to explore interactions with other transcription factors, eects on cytoskeleton, or the role of p53 in responding to extracellular stimuli such as growth factors or microorganisms.
Materials and methods

Materials
4-OH tamoxifen was purchased from Research Biochemicals Int. (Cat. no. T-156, Natick MA) and stored at 7208C as a stock solution of 1 mM in dimethyl sulfoxide. A working stock of 100 mM in DMSO was used for direct addition to cultured cells. Puromycin was purchased from Sigma and stored at 7208C as a sterile solution of 1 mg/ml in water. Cis-platinum was the generous gift of Dr Noa Ben-Baruch; it was used as a stock solution of 1 mg/ml (®nal concentration 20 mg/ml) in PBS. Fetal bovine serum was purchased from BioLab biologicals, Israel. Media and other cell culture materials were provided by the Weizmann Institute Media Facility.
Cells and plasmids
Hep 3B cells were maintained in DMEM containing 10% fetal calf serum and antibiotics, except for experiments utilizing serum free conditions. H1299val135 cells were derived by stable transfection of the human lung adenocarcinoma line H1299 with pLTRcGval135 (Michalovitz et al., 1990) . These cells express high levels of p53val135, and undergo a growth arrest at 328C (Y Haupt and M Oren, unpublished) . The following cDNAs were used for transfections: pBpuro (Morgenstern and Land, 1990) , pLTRp53cGval135 (p53val135), encoding a temperature sensitive mutant of mouse p53 (Michalovitz et al., 1990) , or p53-mER tm -pBpuro (Vater et al., 1996) . At 378C, p53val135 is in a mutant conformation and can transform cells through a negative dominant mechanism, whereas at the permissive temperature of 328C it becomes transcriptionally active and regains wild-type activity. p53-mER tmpBpuro contains the BamHI fragment of human p53 cloned in frame with-and N-terminally to a modi®ed estrogen receptor containing a gly to arg mutation at residue 525 (Vater et al., 1996) . This mutation renders the hormone binding domain insensitive to estradiol but responsive to the synthetic estrogen 4-OH tamoxifen.
For the preparation of probes for Northern blotting we used: human albumin ± a 514 bp HindIII/HpaII fragment spanning from 7440 to +74 of the human albumin gene (Friedman et al., 1986) . Human p21 and bax cDNA were kindly provided by Drs B Vogelstein and S Korsmeyer, respectively. We used luciferase reporter plasmids containing the cyclin G promoter (Friedlander et al., 1996) or the haptoglobin promoter (Baumann et al., 1987 ) (a gift of Dr Heinz Baumann). To generate the latter, the promoter element of prHp (190)-CT was excised with HindIII/KpnI and subcloned into pGL3 Basic (Promega).
Generation of stable Hep 3B-derived cell clones
Stable Hep 3B cell clones were generated expressing either puromycin resistance alone (control) or in conjunction with either the temperature sensitive mutant p53val135 or the p53-(modi®ed) estrogen receptor chimera. Transfection was performed by calcium phosphate precipitation with either pBpuro alone (0.5 mg), pBpuro (0.5 mg) together with p53val135 (5.0 mg), or p53-mER tm -pBpuro (5.0 mg). Six hours later cells were incubated in 10% glycerol in DMEM for 1 min, restored in standard medium containing serum for 24 h, then trypsinized and replated at several serial dilutions. Two days later puromycin (2 mg/ml ®nal concentration) was added, and cells were maintained under puromycin selection at all times thereafter except during experiments. After approximately 14 ± 21 days puromycin-resistant colonies were recovered and expanded. The cell clones were subsequently maintained in standard culture medium.
Western blotting
Approximately 2 ± 5610 5 Hep 3B cells were washed twice with cold PBS on ice and harvested by scraping with a rubber policeman. Cells were pelleted by centrifugation at 48C and resuspended directly into Laemmli sample buer containing 62.5 mM Tris-HCl, pH 6.8; 2% SDS (w/v) 10% glycerol (w/v) and 5% beta mercaptoethanol (v/v). Pellets were disrupted by high speed sonication for 15 s, followed by boiling for 5 min, then stored at 7208C or used directly for SDS ± PAGE. Samples were separated on 7.5 ± 12% SDS ± PAGE (as indicated in ®gure legends), transferred to nylon membranes, blocked in PBS containing 10% non-fat dried milk and 0.1% Tween. Membranes were incubated overnight at 48C in primary antibodies dissolved in blocking buer, then washed three times in blocking buer (10 min each) and incubated for 45 min in secondary antibody in blocking buer (rabbit anti-mouse IgG). Following the secondary antibody, blots were washed three times in PBS/0.1% Tween, then developed using a commercial chemiluminescence detection kit (Amersham ECL). Primary antibodies were as follows: p53-speci®c monoclonal antibodies PAb 421 (Harlow et al., 1981) PAb 1801 (Banks et al., 1986) and DO-1 (Vojtesek et al., 1992) ; p21 Mab (Pharmingen); ± anti-Mdm2 ± Mab SMP14 (Picksley et al., 1994) and anti-pRb (Pharmingen).
p53 immunostaining
Approximately 2610 5 cells were plated on two chamber glass slides (Nunc) and maintained at either 378C or 328C overnight in standard culture medium. Cells were ®xed for 5 min using ice-cold methanol, washed twice with PBS and incubated at 48C overnight with primary antibody (PAb 421) or PBS (control). Following three washes with PBS, cells were incubated for 1 h in secondary antibody (Rhodamine conjugated donkey anti-mouse IgG diluted 1 : 50 in PBS, Jackson Immunoresearch Laboratories), washed twice and mounted in glycerol. Cells were visualized and photographed on Ilford 400 black and white ®lm using a Nikon Microphot microscope equipped for epi¯uorescence.
Cell cycle and proliferation analysis
For analysis of cell cycle distribution and DNA synthesis, 10 mM Bromodeoxyuridine (BrDU) was added to the cells 30 min prior to harvesting. Cells were harvested by trypsinization, washed in serum free medium, and suspended in 70% ethanol for storage at 48C. Just prior to analysis the cell suspensions were pelleted and resuspended for 20 min in PBS containing 50 mg/ml RNAse. To stain DNA, 25 mg/ml propidium iodide was added (Sigma). Cells were analysed as previously described (Resnitzky and Reed, 1995) using a FACSORT (Becton Dickenson).
Luciferase activity measurement
Approximately 5610 5 cells in 60 mm plastic dishes were washed twice and harvested into PBS, pelleted by centrifugation, and suspended in 100 ml commercial lysis buer (Promega). After 15 min at room temperature, 40 ml was assayed for luciferase activity using a Turner Design Luminometer.
Northern blotting
Total RNA was extracted from cells in GITC (Chomczynski and Sacchi, 1987) , and stored at 7708C in sterile water treated with diethylpyrocarbonate. Aliquots of 15 mg were separated on formaldehyde/agarose gels, transferred overnight by capillary blotting in 206SSC onto nylon membranes and ®xed by incubation at 808C under vacuum for 2 h. Probes were prepared by random priming with [ 32 P]dCTP using a commercial kit (Multiprime TM , Amersham), with excised inserts as template. Probes were column puri®ed (NucTrap TM , Stratagene) and approximately 10 7 d.p.m. incubated with the blot overnight at 428C in 50% formamide. Blots were washed to a stringency of 0.56SSC, 428C, and exposed to X-ray ®lm for 3 ± 5 days using an intensifying screen.
